| 000 | 01582 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513041302.0 | ||
| 264 | 0 | _c19950518 | |
| 008 | 199505s 0 0 eng d | ||
| 022 | _a0028-4793 | ||
| 024 | 7 |
_a10.1056/NEJM199505183322003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWarkentin, T E | |
| 245 | 0 | 0 |
_aHeparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cMay 1995 |
||
| 300 |
_a1330-5 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aConfidence Intervals |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aEnoxaparin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHeparin _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulin G _xanalysis |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPlatelet Count |
| 650 | 0 | 4 |
_aPostoperative Complications _xprevention & control |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aThrombocytopenia _xchemically induced |
| 650 | 0 | 4 |
_aThrombophlebitis _xprevention & control |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLevine, M N | |
| 700 | 1 | _aHirsh, J | |
| 700 | 1 | _aHorsewood, P | |
| 700 | 1 | _aRoberts, R S | |
| 700 | 1 | _aGent, M | |
| 700 | 1 | _aKelton, J G | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 332 _gno. 20 _gp. 1330-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJM199505183322003 _zAvailable from publisher's website |
| 999 |
_c7715032 _d7715032 |
||